The scope of pharmacy services has expanded in many Canadian jurisdictions in recent years. This report estimates the health and economic impact of three community pharmacy services that have the potential to be expanded.
The Value of Expanded Pharmacy Services in Canada
The Value of Expanded Pharmacy Services in Canada
Health and Healthcare
$0.00
The scope of pharmacy services has expanded in many Canadian jurisdictions in recent years, with each province and territory taking a different approach to optimize these changes for better health and value.
This report showcases a modelling study that estimates the health and economic impact of three services currently delivered within a community pharmacy setting that have the potential to be expanded: smoking cessation, advanced medication review and management for cardiovascular disease, and pneumococcal vaccination.
Over the 20-year forecast period, the estimated economic value of expanding these services ranges from $2.5 billion to $25.7 billion. We also expect a large return on investment for all three services over the medium and long terms.
Customers Who Downloaded This Also Liked
21 min read
40 min read
Require an accessible version of this research?
Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.
Learn more about our accessibility policies.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
